SCHEMBL7984492

SCHEMBL7984492

NC(=O)c1c(NC(=O)c2cccc(Cl)c2)ncn1Cc1ccccc1

nearest known ligand 0.53

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ADORA2A P29274 2/20 0.53
ADORA3 P0DMS8 4/20 0.49
ADORA2B P29275 1/20 0.49
KDM4E B2RXH2 2/20 0.48
ADORA1 P30542 2/20 0.47
KCNK3 O14649 1/20 0.46
KCNK9 Q9NPC2 1/20 0.46
ALDH1A1 P00352 2/20 0.46
VNN1 O95497 2/20 0.45
CDC7 O00311 1/20 0.44
DAPK3 O43293 1/20 0.44
PAK4 O96013 1/20 0.44
CDK2 P24941 1/20 0.44
FLT3 P36888 1/20 0.44
CSNK1A1 P48729 1/20 0.44
CLK2 P49760 1/20 0.44
GSK3B P49841 1/20 0.44
CDK7 P50613 1/20 0.44
CDK9 P50750 1/20 0.44
PRKX P51817 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7974040 0.95 KDM4E (0.51) ADORA2AADORA3ADORA2BKDM4EADORA1
SCHEMBL7975241 0.90 GAA (0.50) ADORA2AADORA3ADORA2BADORA1FLT3
SCHEMBL7985033 0.88 NLRP3 (0.46) ADORA3KDM4EKCNK3KCNK9ALDH1A1
SCHEMBL7984200 0.88 SMN1; SMN2 (0.53) ADORA3KCNK3ALDH1A1CDC7DAPK3
SCHEMBL7974581 0.88 LMNA (0.51) ADORA3ALDH1A1FLT3
SCHEMBL7988029 0.88 IDO1 (0.47) ADORA3FLT3
SCHEMBL7992620 0.86 NPC1 (0.53) KDM4EALDH1A1YTHDC1
SCHEMBL7984937 0.85 ADORA3 (0.52) ADORA3KDM4EKCNK3KCNK9ALDH1A1
SCHEMBL7985560 0.85 ADORA3 (0.52) ADORA3KCNK3ALDH1A1VNN1KCNQ3
SCHEMBL7984965 0.85 ALDH1A1 (0.57) KDM4EALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6310070-B1 FOR TREATING NEPHRITIS, IMPROVING PROTEINURIA DUE TO GLOMERULONEPHRITIS AND PREVENTING AGGRAVATION OF NEPHRITIS JAPAN ENERGY CORPORATION (JP) 2001-10-30 US disclosed
EP-0999211-A1 NOVEL PURINE DERIVATIVES AND MEDICINAL USE THEREOF JAPAN ENERGY CORPORATION (JP) 2000-05-10 EP disclosed